These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. De novo establishment and cost-effectiveness of Papanicolaou cytology screening services in the Socialist Republic of Vietnam. Suba EJ, Nguyen CH, Nguyen BD, Raab SS, Viet/American Cervical Cancer Prevention Project. Cancer; 2001 Mar 01; 91(5):928-39. PubMed ID: 11251944 [Abstract] [Full Text] [Related]
4. Clinical and cost implications of new technologies for cervical cancer screening: the impact of test sensitivity. Hutchinson ML, Berger BM, Farber FL. Am J Manag Care; 2000 Jul 01; 6(7):766-80. PubMed ID: 11067374 [Abstract] [Full Text] [Related]
6. [A reply on cervix cancer screening: cervical cytological test doesn't fulfil the requirements of a good screening test]. Bistoletti P. Lakartidningen; 2000 Sep 13; 97(37):4042. PubMed ID: 11036367 [No Abstract] [Full Text] [Related]
10. Public expectations, achievable cervical screening sensitivity, and the standard of practice. Austin RM. Cancer; 2003 Feb 25; 99(1):1-3. PubMed ID: 12589638 [No Abstract] [Full Text] [Related]
11. [Population screening for uterine cervix cancer: the negative effects of insufficient knowledge as to what is normal and abnormal]. van der Graaf Y. Ned Tijdschr Geneeskd; 2002 Aug 24; 146(34):1569-71. PubMed ID: 12224477 [Abstract] [Full Text] [Related]
16. Does cervical cancer screening do more harm than good? Payne L, Lavis P. Nurs Times; 2002 Aug 24; 97(29):20. PubMed ID: 11957496 [No Abstract] [Full Text] [Related]
19. A decade has passed...the Pap smear and cervical cancer. Linder J. Am J Clin Pathol; 1997 Nov 24; 108(5):492-8. PubMed ID: 9353086 [No Abstract] [Full Text] [Related]